Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product.   10 February 2026
Novartis takes aim at Tafinlar generic in latest suit
Americas
The Swiss pharma giant moves to protect patents on its billion-dollar cancer therapy following an ANDA filing by a Canadian generics manufacturer.   9 February 2026
Semaglutide patent battle heats up with new blow for Novo in India
Americas
A Delhi High Court ruling signals more bad news for the Danish pharma giant in the same week that it lost nearly $50 billion in value.   6 February 2026
Careers
The New York-based partner will advise biotech, pharma, and technology clients on patent prosecution, IP strategy and venture-backed transactions.   6 February 2026
Asia
The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.   5 February 2026
Europe
Excitement is mounting for the world’s largest IP gathering, which will see the industry’s elites travelling to the UK in the spring, reveals the association’s CEO.   5 February 2026
Careers
The trial group, which brings “exceptional litigation talent”, joins larger firm in Texas and Washington, DC, coinciding with the announcement of the Winston Taylor merger.   5 February 2026
Careers
The new hire, who has clients in pharma and medical devices and diagnostics, will lead the Dublin office's IP & Technology practice.   4 February 2026
Americas
Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners selected by leading industry experts.   3 February 2026
Europe
As legislative activity in life sciences increases, in-house teams are struggling to keep up. Experts share their sources and strategies for monitoring developments, coordinating internally, and knowing when to engage.   3 February 2026